- 专利标题： INHIBITOR OF BTK AND MUTANTS THEREOF
-
申请号： US17764329申请日： 2020-08-20
-
公开(公告)号： US20220363689A1公开(公告)日： 2022-11-17
- 发明人: Yi Chen
- 申请人： Newave Pharmaceutical Inc. , GUANGZHOU LUPENG PHARMACEUTICAL COMPANY LTD.
- 申请人地址： US CA Pleasanton; CN Guangdong
- 专利权人： Newave Pharmaceutical Inc.,GUANGZHOU LUPENG PHARMACEUTICAL COMPANY LTD.
- 当前专利权人： Newave Pharmaceutical Inc.,GUANGZHOU LUPENG PHARMACEUTICAL COMPANY LTD.
- 当前专利权人地址： US CA Pleasanton; CN Guangdong
- 优先权： USPCT/US2020/019478 20200224
- 国际申请： PCT/US2020/047196 WO 20200820
- 主分类号： C07D495/04
- IPC分类号： C07D495/04 ; A61P35/00
摘要：
The disclosure includes compounds of Formula (I) wherein Q0, Q1, Q2, Q3, Q4, Z, W, i, j, m, n, Warhead, R0, R1, R3, R4, R5, R6, and R7, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.
信息查询
